![IMA new masthead1](https://prodcraftsa01.blob.core.windows.net/assets/products/internal-medicine-alert/_contentImage/IMA_new_masthead1.png)
Internal Medicine Alert – June 15, 2014
June 15, 2014
View Issues
-
Early Intensive Therapy in Patients with Type 2 Diabetes Reduces Glycemic Variability: What Are the Clinical Implications?
Sixty-one patients with type 2 diabetes discontinued their prescribed antihyperglycemic agents and underwent 4 weeks of intensive insulin therapy. A total of 56% of patients demonstrated a reduction in glycemic variability and improvement in beta-cell function. -
Primary Nonadherence to Prescription Drugs Widespread
In a study of primary care patients, primary nonadherence was found to be common and may be improved by eliminating cost barriers as well as more frequent physician visits. -
Who Should be Referred for Advanced Heart Failure Care?
The authors concluded that more than one of five simple risk factors for death would be an indication to explore advanced therapies in systolic HF patients < 80 years of age. -
Pharmacology Update: Timothy Grass Pollen Allergen Extract Sublingual Tablets (Grastek®)
The FDA has approved a second pollen extract as immunotherapy to treat grass pollen-induced allergic rhinitis -
Clinical Briefs
-
ECG Review: Is the Q Wave and T Inversion Normal?